Filing Details

Accession Number:
0000950170-24-028827
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-08 18:05:06
Reporting Period:
2024-03-08
Accepted Time:
2024-03-08 18:05:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680581 Fulcrum Therapeutics Inc. FULC Pharmaceutical Preparations (2834) 474839948
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1916566 Greg Tourangeau C/O Fulcrum Therapeutics, Inc.
26 Landsdowne Street
Cambridge MA 02139
Vice President, Finance No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-08 4,884 $11.72 11,807 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.74, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. Includes 699 shares acquired under the Issuer's employee stock purchase plan on May 13, 2022.